Conditions: Healthy
Allocation: NON_RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 13
Healthy volunteers: yes

Brief summary:
The trial was designed to investigate whether, and to which extent, multiple doses of bosentan may influence the plasma levels of nintedanib administered as a single dose.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Bosentan intervention 2: Nintedanib
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: